Related references
Note: Only part of the references are listed.Targeting prostate cancer: Prostate-specific membrane antigen based diagnosis and therapy
Till Wuestemann et al.
MEDICINAL RESEARCH REVIEWS (2019)
Stromal Gene Expression is Predictive for Metastatic Primary Prostate Cancer
Fan Mo et al.
EUROPEAN UROLOGY (2018)
Molecular Subtypes of Prostate Cancer
Kaveri Arora et al.
CURRENT ONCOLOGY REPORTS (2018)
Therapeutic Targeting of the CBP/p300 Bromodomain Blocks the Growth of Castration-Resistant Prostate Cancer
Lingyan Jin et al.
CANCER RESEARCH (2017)
Genetic traits for hematogeneous tumor cell dissemination in cancer patients
Simon A. Joosse et al.
CANCER AND METASTASIS REVIEWS (2016)
Patient-Derived Xenograft Models for Pancreatic Adenocarcinoma Demonstrate Retention of Tumor Morphology through Incorporation of Murine Stromal Elements
Daniel Delitto et al.
AMERICAN JOURNAL OF PATHOLOGY (2015)
High Fidelity Patient-Derived Xenografts for Accelerating Prostate Cancer Discovery and Drug Development
Dong Lin et al.
CANCER RESEARCH (2014)
Aberrant Presentation of HPA-Reactive Carbohydrates Implies Selectin-Independent Metastasis Formation in Human Prostate Cancer
Tobias Lange et al.
CLINICAL CANCER RESEARCH (2014)
The BALB/c-specific polymorphic SIRPA enhances its affinity for human CD47, inhibiting phagocytosis against human cells to promote xenogeneic engraftment
Chika Iwamoto et al.
EXPERIMENTAL HEMATOLOGY (2014)
LSD1 controls metastasis of androgen-independent prostate cancer cells through PXN and LPAR6
A. Ketscher et al.
ONCOGENESIS (2014)
Crosstalk between CTC, Immune System and Hypoxic Tumor Microenvironment
Muhammad Zaeem Noman et al.
CANCER MICROENVIRONMENT (2014)
Dormancy in solid tumors: implications for prostate cancer
Nazanin S. Ruppender et al.
CANCER AND METASTASIS REVIEWS (2013)
Mechanisms Governing Metastatic Dormancy and Reactivation
Filippo G. Giancotti
CELL (2013)
Differential analysis of gene regulation at transcript resolution with RNA-seq
Cole Trapnell et al.
NATURE BIOTECHNOLOGY (2013)
PARP Inhibition Sensitizes to Low Dose-Rate Radiation TMPRSS2-ERG Fusion Gene-Expressing and PTEN-Deficient Prostate Cancer Cells
Payel Chatterjee et al.
PLOS ONE (2013)
Targeted Radiosensitization of ETS Fusion-Positive Prostate Cancer through PARP1 Inhibition
Sumin Han et al.
NEOPLASIA (2013)
Control-FREEC: a tool for assessing copy number and allelic content using next-generation sequencing data
Valentina Boeva et al.
BIOINFORMATICS (2012)
Immunohistochemistry for ERG Expression as a Surrogate for TMPRSS2-ERG Fusion Detection in Prostatic Adenocarcinomas
Alcides Chaux et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2011)
Global Cancer Statistics
Ahmedin Jemal et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2011)
ERG Status Is Unrelated to PSA Recurrence in Radically Operated Prostate Cancer in the Absence of Antihormonal Therapy
Sarah Minner et al.
CLINICAL CANCER RESEARCH (2011)
Tumor grafts derived from women with breast cancer authentically reflect tumor pathology, growth, metastasis and disease outcomes
Yoko S. DeRose et al.
NATURE MEDICINE (2011)
Patients with Localised Prostate Cancer (T1-T2) Show Improved Overall Long-Term Survival Compared to the Normal Population
Michael J. Mathers et al.
JOURNAL OF CANCER (2011)
Establishment and Genomic Characterization of Mouse Xenografts of Human Primary Prostate Tumors
Carmen Priolo et al.
AMERICAN JOURNAL OF PATHOLOGY (2010)
ANNOVAR: functional annotation of genetic variants from high-throughput sequencing data
Kai Wang et al.
NUCLEIC ACIDS RESEARCH (2010)
Steroid Hormone Receptors in Prostate Cancer: A Hard Habit to Break?
Gerhardt Attard et al.
CANCER CELL (2009)
Ligand-Independent Androgen Receptor Variants Derived from Splicing of Cryptic Exons Signify Hormone-Refractory Prostate Cancer
Rong Hu et al.
CANCER RESEARCH (2009)
From Human to Mouse and Back: Tumorgraft Models Surge in Popularity
Ken Garber
JOURNAL OF THE NATIONAL CANCER INSTITUTE (2009)
TMPRSS2:ERG fusion identifies a subgroup of prostate cancers with a favorable prognosis
Outi R. Saramaki et al.
CLINICAL CANCER RESEARCH (2008)
Molecular characterization of TMPRSS2-ERG gene fusion in the NCI-H660 prostate cancer cell line:: A new perspective for an old model
Kirsten D. Mertz et al.
NEOPLASIA (2007)
Establishment in severe combined immunodeficiency mice of subrenal capsule xenografts and transplantable tumor lines from a variety of primary human lung cancers: Potential models for studying tumor progression-related changes
Jean-Claude Cutz et al.
CLINICAL CANCER RESEARCH (2006)
Increased expression of genes converting adrenal androgens to testosterone in androgen-independent prostate cancer
M Stanbrough et al.
CANCER RESEARCH (2006)
Development and characterization of efficient xenograft models for benign and malignant human prostate-tissue
YZ Wang et al.
PROSTATE (2005)
The androgen axis in recurrent prostate cancer
JL Mohler et al.
CLINICAL CANCER RESEARCH (2004)
Molecular determinants of resistance to antiandrogen therapy
CD Chen et al.
NATURE MEDICINE (2004)
Metastatic patterns of prostate cancer:: An autopsy study of 1,589 patients
L Bubendorf et al.
HUMAN PATHOLOGY (2000)
Quantitative assessment of spontaneous lung metastases of human HT29 colon cancer cells transplanted into SCID mice
M Jojovic et al.
CANCER LETTERS (2000)
Share Paper
